BCYC
Price
$19.94
Change
-$0.15 (-0.75%)
Updated
Oct 2, 1:36 PM EST
31 days until earnings call
IMTX
Price
$11.58
Change
+$0.57 (+5.18%)
Updated
Sep 29, 6:59 PM EST
44 days until earnings call

Compare trend and price BCYC vs IMTX

Header iconBCYC vs IMTX Comparison
Open Charts BCYC vs IMTXBanner chart's image
Bicycle Therapeutics
Price$19.94
Change-$0.15 (-0.75%)
Volume$200
CapitalizationN/A
Immatics
Price$11.58
Change+$0.57 (+5.18%)
Volume$328.77K
CapitalizationN/A
View a ticker or compare two or three
BCYC vs IMTX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
BCYC vs. IMTX commentary
Oct 02, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and IMTX is a Hold.

COMPARISON
Comparison
Oct 02, 2023
Stock price -- (BCYC: $20.11 vs. IMTX: $11.58)
Brand notoriety: BCYC and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 37% vs. IMTX: 162%
Market capitalization -- BCYC: $742.74M vs. IMTX: $931.01M
BCYC [@Biotechnology] is valued at $742.74M. IMTX’s [@Biotechnology] market capitalization is $931.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $410.54B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 0 FA rating(s) are green whileIMTX’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 0 green, 5 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMTX is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 2 TA indicator(s) are bullish while IMTX’s TA Score has 5 bullish TA indicator(s).

  • BCYC’s TA Score: 2 bullish, 5 bearish.
  • IMTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а +0.10% price change this week, while IMTX (@Biotechnology) price change was -1.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.39%. For the same industry, the average monthly price growth was +18.43%, and the average quarterly price growth was +21.40%.

Reported Earning Dates

BCYC is expected to report earnings on Nov 02, 2023.

IMTX is expected to report earnings on Nov 15, 2023.

Industries' Descriptions

@Biotechnology (+0.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
A.I.dvisor published
a Summary for IMTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
IMTX($931M) has a higher market cap than BCYC($743M). IMTX YTD gains are higher at: 32.951 vs. BCYC (-32.061). IMTX has higher annual earnings (EBITDA): -67.02M vs. BCYC (-132.66M). IMTX (348M) and BCYC (340M) have equal amount of cash in the bank . IMTX has less debt than BCYC: IMTX (16.8M) vs BCYC (47.1M). IMTX has higher revenues than BCYC: IMTX (84.9M) vs BCYC (22.5M).
BCYCIMTXBCYC / IMTX
Capitalization743M931M80%
EBITDA-132.66M-67.02M198%
Gain YTD-32.06132.951-97%
P/E RatioN/A16.39-
Revenue22.5M84.9M27%
Total Cash340M348M98%
Total Debt47.1M16.8M280%
TECHNICAL ANALYSIS
Technical Analysis
BCYCIMTX
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
69%
Momentum
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
46%
MACD
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
60%
Advances
ODDS (%)
Bullish Trend 13 days ago
87%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 8 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
55%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LEOIX8.270.02
+0.24%
Lazard Enhanced Opportunities Instl
PIPPX8.55N/A
N/A
Principal MidCap Growth R4
TIBCX22.30-0.01
-0.04%
Thornburg Investment Income Builder C
ISRYX12.27-0.03
-0.24%
AB International Low VolatilityEqPortAdv
LSIRX36.79-0.14
-0.38%
ClearBridge Mid Cap IS

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-0.59%
PHIO - BCYC
41%
Loosely correlated
+2.72%
MLTX - BCYC
39%
Loosely correlated
+0.60%
ORMP - BCYC
35%
Loosely correlated
+3.98%
SAGE - BCYC
34%
Loosely correlated
-0.58%
ALPN - BCYC
34%
Loosely correlated
+1.42%
More

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with FATE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+5.18%
FATE - IMTX
41%
Loosely correlated
-2.29%
KNSA - IMTX
36%
Loosely correlated
-0.29%
CYTK - IMTX
36%
Loosely correlated
-4.35%
SNPX - IMTX
31%
Poorly correlated
+5.28%
AXON - IMTX
31%
Poorly correlated
+1.48%
More